210,902 results on '"KIDNEY diseases"'
Search Results
2. LncRNA MALAT1 as a potential diagnostic and therapeutic target in kidney diseases
3. MiR-363: A potential biomarker of kidney diseases
4. Clonal monocytosis of renal significance
5. Rapid determination of urinary oxalic acid concentration aids in the screening and monitoring of kidney diseases: An LC-ESI-MS/MS method that does not require complex derivatization, acidification treatment, or large-volume sample consumption
6. The significance of ferroptosis in renal diseases and its therapeutic potential
7. Diagnostic methods employing kidney biomarkers clinching biosensors as promising tools
8. Continuous Glucose Monitoring in People With Diabetes on Dialysis (RECORD)
9. Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
10. Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
11. A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
12. Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
13. Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis Patients
14. A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART) (ImPart)
15. PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis (PReSeRVE-HD)
16. Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
17. meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis (CANARY)
18. Multicultural Healthy Diet in Chronic Kidney Disease
19. Trial of JMKX003142 in Participants with Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
20. Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study (PRECISE)
21. Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
22. A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy (ALMOND)
23. Atrasentan in Patients With Proteinuric Glomerular Diseases (AFFINITY)
24. PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia (PRIORITY-CKD)
25. Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients (KPoP)
26. A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
27. Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
28. A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis
29. Low-Protein Diet with Low-Protein Foods Versus a LPD Without LP Foods in Patients with Chronic Kidney Disease (CKD)
30. Lipid Profile in Diabetic and Non Diabetic CKD Patients (CKD)
31. Silymarin's Advantage on Graft Effectiveness (SAGE)
32. The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients. (FAA)
33. TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation
34. Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
35. Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy (IGNAZ)
36. Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease
37. CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes (BRAVO)
38. A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
39. Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) (NewPLACE)
40. Integrating Conservative Kidney Management Options and Advance Care Planning Into a Pre-Dialysis Educational Program
41. Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
42. Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
43. Phase 2b Open-label Study of Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease
44. Light Therapy in End Stage Kidney Disease
45. A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
46. A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
47. Transformative Research in Diabetic Nephropathy (TRIDENT)
48. Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients
49. Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia (PLUTO)
50. Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (SANCTUARY)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.